Complete AI committee score history · 23 sessions recorded · Updated nightly
| Date | Score | Rating | Recommendation | Conviction | Agreement | Analysts |
|---|---|---|---|---|---|---|
| 2026-08-01 | 58.6 | Buy | Buy | Contested | 57% | 7 |
| 2026-07-31 | 59.8 | Buy | Buy | Contested | 57% | 7 |
| 2026-07-30 | 59.4 | Buy | Buy | Contested | 57% | 7 |
| 2026-07-29 | 56.5 | Buy | Buy | Moderate | 60% | 5 |
| 2026-07-28 | 56.5 | Buy | Buy | Moderate | 60% | 5 |
| 2026-07-27 | 61.8 | Buy | Buy | Contested | 57% | 7 |
| 2026-07-26 | 61.8 | Buy | Buy | Contested | 57% | 7 |
| 2026-07-25 | 60.7 | Buy | Buy | Contested | 57% | 7 |
| 2026-07-24 | 60.7 | Buy | Buy | Contested | 57% | 7 |
| 2026-07-23 | 61.8 | Buy | Buy | Contested | 57% | 7 |
| 2026-07-22 | 61.8 | Buy | Buy | Contested | 57% | 7 |
| 2026-07-21 | 61.8 | Buy | Buy | Contested | 57% | 7 |
| 2026-07-20 | 61.8 | Buy | Buy | Contested | 57% | 7 |
| 2026-07-19 | 61.5 | Buy | Buy | Contested | 57% | 7 |
| 2026-07-18 | 61.5 | Buy | Buy | Contested | 57% | 7 |
| 2026-07-17 | 61.5 | Buy | Buy | Contested | 57% | 7 |
| 2026-07-16 | 62.6 | Buy | Buy | Contested | 57% | 7 |
| 2026-07-15 | 62.6 | Buy | Buy | Contested | 57% | 7 |
| 2026-07-14 | 60.5 | Buy | Buy | Moderate | 60% | 5 |
| 2026-07-13 | 65.5 | Buy | Buy | Moderate | 71% | 7 |
| 2026-07-12 | 64.5 | Buy | Buy | Moderate | 60% | 5 |
| 2026-07-11 | 64.5 | Buy | Buy | Moderate | 60% | 5 |
| 2026-07-10 | 65.5 | Buy | Buy | Moderate | 71% | 7 |
About This Data
Committee scores are generated nightly by Innellis's 7-analyst AI committee. Each session analysts independently score Regeneron Pharmaceuticals across fundamentals, momentum, and risk — then debate and reach a consensus. Scores range from 0 (most bearish) to 100 (most bullish). View track record →